News
Broc Shot is the first supplement to earn the Seal of Recognition from the National Psoriasis Foundation (NPF). This recognition highlights Broc Shot’s support for skin health from within, offering a ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
Patients with chronic spontaneous urticaria experience inadequate symptom control and significant emotional burdens despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results